I don't think they would intentionally hurt retail investors (I am one). The options are 1:3 and unlisted, doesn't make much sense for SPP take ups between $2.5k - $15k
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025